Response to: ‘Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?’ by Sabio
Open Access
- 7 May 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (4), e58
- https://doi.org/10.1136/annrheumdis-2020-217641
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?Annals Of The Rheumatic Diseases, 2020
- Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trialAnnals Of The Rheumatic Diseases, 2019
- Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experienceRMD Open, 2019
- Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trialAnnals Of The Rheumatic Diseases, 2008
- Randomized withdrawal of long‐term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral densityScandinavian Journal of Rheumatology, 2007
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusThe New England Journal of Medicine, 1991